{"pub": "marketwatch", "url": "https://marketwatch.com/story/biogens-stock-soars-toward-record-rally-set-to-add-nearly-17-billion-to-market-cap-2019-10-22", "downloaded_at": "2019-10-22 13:25:03.778529+00:00", "title": "Biogen's stock soars toward record rally, set to add nearly $17 billion to market cap", "language": "en", "text": "Shares of Biogen Inc. BIIB, +1.57% soared 40.5% on heavy volume toward a record gain in premarket trading Tuesday, after the biotechnology company said it will pursue FDA approval of its Alzheimer's treatment aducanumab after upbeat trial results and reported a third-quarter profit that was well above expectations. Trading volume was about 1.4 million shares, compared with the full-day average of 1.8 million shares. The stock's biggest one-day gain since going public in September 1991 was 27.5% on April 20, 1999. The implied price gain ahead of the open would add about $16.7 billion to Biogen's market capitalization. Biogen's stock had tumbled 29.2% over the past 12 months through Monday, while the S&P 500 SPX, +0.69% had gained 9.1%.", "description": "Shares of Biogen Inc. soared 40.5% on heavy volume toward a record gain in premarket trading Tuesday, after the biotechnology company said it will pursue FDA...", "authors": ["Tomi Kilgore", "Reporter"], "top_image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "published_at": "2019-10-22"}